Utility of the SomaLogic Cardiovascular Disease (CVD) Secondary Risk Panel for Cardiovascular Risk
Clinical trial NCT03599531 · COMPLETED
Trial details
- NCT number
- NCT03599531
- Sponsor
- SomaLogic, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-06-13
- Primary completion
- 2020-10-10
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.